Rubella Vaccine Persistence Within Cutaneous Granulomas in Common Variable Immunodeficiency Disorder

Area of Science:

• Immunology
• Dermatology
• Pathology

Background:

• Common variable immunodeficiency disorder (CVID) is a primary immunodeficiency characterized by low immunoglobulin levels and poor antibody response.
• CVID patients may develop disfiguring, destructive noninfectious granulomatous dermatitis.
• Current treatment guidelines for CVID-associated cutaneous granulomas are lacking.

Observation:

• A case of treatment-refractory granulomatous dermatitis associated with CVID is presented.
• Immunofluorescence microscopy revealed rubella vaccine capsid proteins within M2 macrophages in the granuloma biopsy.
• This finding of rubella virus-positive cells in M2 macrophages is a newly recognized phenomenon in this patient population.

Findings:

• M2 macrophages, involved in wound healing and cytokine secretion, were found to harbor rubella vaccine capsid proteins in granulomas.
• The presence of these proteins suggests a potential link between the rubella vaccine and granuloma formation in CVID.

Implications:

• Identifying rubella vaccine proteins in granulomas offers novel insights into CVID-associated dermatitis.
• This discovery may pave the way for developing targeted therapeutic strategies for granulomatous dermatitis in primary immunodeficiency disorders.
• Further research could explore preventative measures against vaccine-associated granuloma formation in susceptible patients.